Browse the evidence

Structural modifications such as amino acid substitutions and PEGylation enhance stability and extend half-life of diabetes therapeutics.

Incorporating these modifications can improve the efficacy of diabetes treatments.

Tirzepatide can cause acute hepatocellular liver injury in patients.

Clinicians should monitor liver function in patients using tirzepatide.

Hepatotoxicity is not a widely recognized complication of tirzepatide.

Awareness of potential liver injury should be increased among healthcare providers prescribing tirzepatide.

Symptoms of liver injury resolved and liver enzymes normalized within 3 weeks of presentation.

Patients may recover from tirzepatide-induced liver injury with appropriate monitoring.

Diabetes Mellitus (DM) is caused by interactions between multiple factors and triggers.

Understanding the multifactorial nature of DM can guide prevention and treatment strategies.

Numerous medications for diabetics have been developed to help alleviate the symptoms of hyperglycemia.

Practitioners can utilize a variety of medications to manage hyperglycemia in diabetic patients.

Some factors and mechanisms involved in DM development are controversial and have contradicting experimental results.

Awareness of controversial factors can inform research directions and clinical approaches.

The previous version of the guideline did not include a literature review for obesity surgery due to limited resources, and it references an existing guideline for obesity surgery.

Clinicians should be aware of the referenced guidelines for obesity surgery when making treatment decisions.

iWAT injection of MPDA@TZP improved leptin resistance, beiging, lipid metabolism, mitochondrial activity, and branched-chain amino acid (BCAA) catabolism in iWAT.

Understanding these metabolic improvements can guide targeted therapies for obesity.

Leptin receptor deficiency in db/db mice abolished the weight reduction effect of MPDA@TZP via iWAT local injection compared to that in DIO mice.

Leptin receptor status should be considered when evaluating treatment efficacy for obesity.

More work is needed to understand the mechanisms and full potential of antiobesity medicines in cancer.

Ongoing research is essential to fully understand the implications of antiobesity medications on cancer.

HMB supplementation failed to demonstrate significant benefits for muscle strength (SMD = -0.22, 95% CI: -0.57, 0.12) or mass outcomes (MD = 0.05, 95% CI: -0.33, 0.44).

HMB supplementation may not be effective for improving muscle strength or mass in older adults.

The present study did not find an association between resistance training (RT) and all-cause mortality.

Resistance training may not significantly impact overall mortality risk.

Neither meeting the guidelines nor monthly RT volume was associated with all-cause mortality in adjusted models.

Adherence to resistance training guidelines or volume does not appear to influence mortality risk.

Defects in mitochondrial oxidative phosphorylation contribute to insulin resistance and β-cell apoptosis.

Addressing mitochondrial oxidative phosphorylation may improve insulin sensitivity.

There is a need for more high-quality, large, prospective controlled research to elucidate the role of dietary structure with different fat to carbohydrate ratios across the life cycle of diabetes.

Future research should focus on dietary ratios to better inform diabetes management strategies.

The reanalysis ignored the within-participant, repeated-measures structure of the data.

Understanding the importance of proper statistical methods is crucial for accurate dietary research interpretation.

The reanalysis reported incorrect statistical comparisons and optimistic p-values.

Practitioners should critically evaluate statistical results in dietary studies to avoid misinterpretation.

More people around the world now have obesity than suffer from starvation.

This indicates a need for urgent public health interventions to address obesity.

The energy available in the United States food supply increased much more than population needs.

This suggests that dietary guidelines should address energy intake relative to needs.

Substantial investments in coordinated nutrition and agricultural research are needed to transform the food system.

This highlights the importance of policy and research in addressing obesity and food security.

No significant findings emerged in White women, African American men, or for the 8-10 week outcomes or for waist-to-hip ratio adjusted for body mass index (WHRadjBMI).

Practitioners should be cautious in generalizing findings across different demographic groups.

Early treatment with the DPP-4 inhibitor, sitagliptin, did not lead to better glycemic control than placebo and did not prevent posttransplant diabetes (PTD).

Practitioners should reconsider the use of sitagliptin for preventing PTD in kidney transplant patients.

The study failed to observe a statistically significant difference in the primary efficacy measure of ≥20 mg/dl difference in the 2-h OGTT at 3 months.

The lack of significant difference suggests that sitagliptin may not be effective in improving glucose tolerance in this population.